NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Applovin
APP
US Stock MarketDetailed Quotes
INO Inovio Pharmaceuticals
- 1.9800
- 0.00000.00%
Close Feb 26 16:00 ET
- 2.0000
- +0.0200+1.01%
Post 19:39 ET
71.48MMarket Cap-0.45P/E (TTM)
2.0600High1.9000Low573.32KVolume1.9800Open1.9800Pre Close1.14MTurnover1.76%Turnover RatioLossP/E (Static)36.10MShares14.748052wk High0.97P/B64.48MFloat Cap1.740052wk Low--Dividend TTM32.57MShs Float2352.0000Historical High--Div YieldTTM8.08%Amplitude1.7400Historical Low1.9900Avg Price1Lot Size
Inovio Pharmaceuticals Stock Forum
“Phase 1/2 data due to be presented at AACR-IO on February 23-26, 2025. BLA submission due in mid-2025. New immunology on Phase 1/2 data shows INO-3107 induced an expansion of new clonal T cells in blood that were not detectable prior to treatment, noted November 13, 2024.”
｡ﾟ* ҉* ੈ‧₊ ｡ﾟnot financial advice
Breakthrough RRP Treatment Slashes Surgery Need: 28% of Patients Now Surgery-Free in Nature Communications Study
INOVIO Announces Phase 1/2 Trial Results Of INO-3107 For Recurrent Respiratory Papillomatosis With 81% Of Patients Requiring Fewer Surgeries; Plans BLA Submission In Mid-2025 For FDA Accelerated Approval, Aiming To Achieve First US DNA Medicine Approval
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, ...
Complete Response Data: INOVIO's INO-3107 Shows HPV Elimination in RRP Patients
Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference
Monday, 10th February at 8:05 am
Poster will describe loss of detectable HPV-6 in Recurrent Respiratory Papillomatosis patients following treatment with INO-3107
PLYMOUTH MEETING, Pa., Feb. 10, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to...
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release
7. Remember, some stocks may get pumped WITHOUT any catalyst
8. NEVER be a blind follower.
LASTLY, If y...
$Aethlon Medical (AEMD.US)$
$BioCryst Pharmaceuticals (BCRX.US)$
$CureVac (CVAC.US)$
$GeoVax Labs (GOVX.US)$
$Inovio Pharmaceuticals (INO.US)$
$Nanoviricides (NNVC.US)$
$China SXT Pharmaceuticals (SXTC.US)$
$Virax Biolabs (VRAX.US)$
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours)
7. Remember, ...
No comment yet